Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
May 13, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
May 13, 2024 144

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

View HTML
May 9, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 9, 2024 4

Statement of changes in beneficial ownership of securities

View HTML
April 25, 2024 DEFA14A

Additional proxy soliciting materials - definitive

View HTML
April 25, 2024 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 25, 2024 ARS

An annual report to security holders

View HTML
April 23, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
April 16, 2024 8-K

Report of unscheduled material events or corporate event

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us